Fund Holdings — Camber Capital Management LP

Total Portfolio Value:
$717.90M
Total Bought:
$131.49M
Total Sold:
$1.01B
Net Transaction:
-$879.58M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Zimmer Biomet Holdings, Inc.(ZBH)2,250,0001,000,000-1,250,000$254.66M$91.21M12.71%-$163.44M
Baxter Intl Inc5,750,0002,850,000-2,900,000$196.82M$86.30M12.02%-$110.52M
Humana Inc.(HUM)725,000300,000-425,000$191.84M$73.34M10.22%-$118.49M
CVS Health Corporation(CVS)2,250,0001,050,000-1,200,000$152.44M$72.43M10.09%-$80.01M
Globus Medical, Inc.CL A(GMED)1,250,000800,000-450,000$91.50M$47.22M6.58%-$44.28M
ICON Public Limited CompanySHS(ICLR)0300,000+300,000$0$43.63M6.08%+$43.63M
Ascendis Pharma A/SADR(ASND)350,000250,000-100,000$54.55M$43.15M6.01%-$11.40M
Merck & Co., Inc.(MRK)0500,000+500,000$0$39.58M5.51%+$39.58M
Pfizer Inc.(PFE)2,500,0001,500,000-1,000,000$63.35M$36.36M5.06%-$26.99M
BioMarin Pharmaceutical Inc.(BMRN)500,000600,000+100,000$35.34M$32.98M4.59%-$2.36M
UnitedHealth Group Incorporated(UNH)0100,000+100,000$0$31.20M4.35%+$31.20M
Viatris Inc.(VTRS)7,500,0002,750,000-4,750,000$65.33M$24.56M3.42%-$40.77M
Brookdale Senior Living Inc.(BKD)6,250,0002,150,000-4,100,000$39.13M$14.96M2.08%-$24.16M
Zimvie Inc1,885,0001,600,000-285,000$20.36M$14.96M2.08%-$5.40M
Apellis Pharmaceuticals Inc
COM
0850,000+850,000$0$14.71M2.05%+$14.71M
Myriad Genetics, Inc.(MYGN)2,350,0002,000,000-350,000$20.84M$10.62M1.48%-$10.22M
Evolent Health, Inc.CL A(EVH)3,000,000850,000-2,150,000$28.41M$9.57M1.33%-$18.84M
Concentra Group Holdings Parent, Inc.(CON)1,600,000400,000-1,200,000$34.72M$8.23M1.15%-$26.49M
Inogen, Inc.(INGN)975,000975,0000$6.95M$6.85M0.95%-$97.5K
Denali Therapeutics Inc.(DNLI)1,250,000400,000-850,000$16.99M$5.60M0.78%-$11.40M
Theravance Biopharma Inc1,000,000450,000-550,000$8.93M$4.96M0.69%-$3.97M
Anaptysbio Inc750,000125,000-625,000$13.94M$2.77M0.39%-$11.17M
OraSure Technologies, Inc.(OSUR)900,000900,0000$3.03M$2.70M0.38%-$333.0K
10x Genomics, Inc.CL A(TXG)1,000,0000-1,000,000$8.73M$0—-$8.73M
Genmab A/SADS(GMAB)50,0000-50,000$979.0K$0—-$979.0K
Ionis Pharmaceuticals, Inc.(IONS)725,0000-725,000$21.87M$0—-$21.87M
MoonLake ImmunotherapeuticsCL A(MLTX)441,0000-441,000$17.23M$0—-$17.23M
PTC Therapeutics, Inc.(PTCT)1,500,0000-1,500,000$76.44M$0—-$76.44M
Qiagen N.V.(QGEN)1,400,0000-1,400,000$56.21M$0—-$56.21M
Sarepta Therapeutics, Inc.(SRPT)800,0000-800,000$51.06M$0—-$51.06M
Structure Therapeutics IncADS300,0000-300,000$5.19M$0—-$5.19M
The Cigna Group(CI)200,0000-200,000$65.80M$0—-$65.80M
Page 1 of 1
Camber Capital Management LP — 13F Holdings — Q2 2025 | TickerTrail